Breast cancer is often associated with women in their 50s, 60s and beyond.
That association isn’t surprising. Breast cancer risk generally increases with age, and routine screening recommendations have historically focused heavily on middle-aged and older women.
But a new research initiative is directing attention toward a different group: women diagnosed before age 45.
In September 2026, The Estée Lauder Companies Charitable Foundation announced a $15 million commitment over five years to the Breast Cancer Research Foundation to establish the Global Research Initiative on Breast Cancer in Younger Women.
The project will bring together scientists from around the world to investigate why breast cancer develops in younger women, how those cancers may differ biologically and what could improve prevention, early detection and treatment.
The announcement comes amid concern about rising breast cancer diagnoses among younger women and questions about whether existing research adequately addresses their needs.
For families, the initiative raises an important issue that extends beyond Breast Cancer Awareness Month.
What happens when a woman develops a disease she has been taught to associate primarily with someone much older?
Breast Cancer Diagnoses Among Younger Women Have Been Increasing
According to information highlighted by the Breast Cancer Research Foundation and reported by People, breast cancer diagnoses among women younger than 45 increased by approximately 11% between 2012 and 2022.
That figure describes a change in diagnoses over the specified period. It does not mean that 11% of all women younger than 45 developed breast cancer.
Breast cancer remains less common among younger women than among older women.
Nevertheless, the increase has drawn attention from researchers who want to understand what may be contributing to the trend.
The new initiative will focus on early-onset breast cancer and examine questions that may not be fully addressed by research centered on older patients.
The researchers want to better understand the biological mechanisms involved, identify factors that influence risk and improve approaches to detecting and treating the disease.
The ultimate goal is to develop knowledge that can lead to more effective care for younger patients.
The $15 Million Commitment Will Support Five Years of Research
The Estée Lauder Companies Charitable Foundation announced the funding commitment on September 23, 2026.
The money will support the Breast Cancer Research Foundation’s Global Research Initiative on Breast Cancer in Younger Women.
The program is designed to connect researchers across countries and scientific disciplines.
Its initial work will focus on understanding the biology of breast cancer that develops at younger ages.
That includes investigating how tumors arise, what makes certain cancers behave differently and how scientists might improve risk prediction.
The research also aims to advance prevention, early detection and treatment.
The funding is a commitment to research, not the announcement of a newly approved screening test or a treatment already shown to improve outcomes.
Scientific discoveries may take years to develop and evaluate.
But the initiative reflects growing recognition that younger women deserve focused attention within breast cancer research.
Younger Women’s Breast Cancers Can Present Different Challenges
Breast cancer is not one single disease.
Tumors can differ in their biological characteristics, growth patterns and responses to treatment.
Some cancers have receptors that allow doctors to use targeted hormonal treatments.
Others may be HER2-positive and respond to therapies designed for that biological pathway.
Still others lack those markers and require different treatment strategies.
Younger women can develop any of these forms of breast cancer.
However, some aggressive tumor types are more common among younger patients, and cancers in younger women may be diagnosed at more advanced stages.
That doesn’t mean every younger woman develops an aggressive cancer.
It means age can be relevant when researchers examine patterns across groups of patients.
The new initiative is intended to help clarify those differences rather than assuming findings from older populations always apply in exactly the same way.
Elizabeth Hurley Has Spent More Than 30 Years Supporting Breast Cancer Awareness
Actress Elizabeth Hurley has been involved with The Estée Lauder Companies’ Breast Cancer Campaign since 1995.
She began working with Evelyn H. Lauder, who founded the Breast Cancer Research Foundation in 1993 and helped establish the pink ribbon as a widely recognized symbol of breast cancer awareness.
Hurley has remained a prominent advocate for research and early detection.
In an October 9 interview with People, she reflected on how dramatically breast cancer treatment has changed during the past three decades.
Researchers now understand far more about the biological differences between breast cancers, and targeted therapies have transformed treatment for some patients.
But Hurley emphasized that important questions remain about cancers diagnosed in younger women.
Her interest in the cause is also personal.
Her grandmother died from breast cancer, and Hurley has spoken about how that loss influenced her commitment to awareness and research.
For her, the new funding initiative represents another opportunity to address questions that scientists have not yet fully answered.
One Survivor’s Experience Shows Why Younger Women May Dismiss Symptoms
The People report also featured breast cancer survivor Bridget Bahl, a fashion entrepreneur and founder of The Bar.
Bahl, 42, was undergoing in vitro fertilization when she noticed a change in her breast.
At first, she wondered whether the change might be related to the hormones involved in fertility treatment.
She later learned that she had an aggressive, fast-growing form of breast cancer.
Her experience illustrates a challenge that can arise when someone notices a physical change but has another seemingly reasonable explanation for it.
Breast tenderness and other changes can occur for many reasons.
Hormonal fluctuations, pregnancy and menstrual cycles can affect breast tissue.
But a new or persistent change shouldn’t automatically be dismissed because a woman is young or because another explanation seems possible.
Bahl’s story is one individual experience, not evidence that fertility treatment caused her cancer.
The report does not establish such a connection.
The relevant lesson is that she noticed something different and eventually sought medical evaluation.
Breast Cancer Symptoms Don’t Always Feel Like a Hard Lump
Many women have heard that breast cancer can cause a lump.
But breast changes can appear in different ways.
A new lump in the breast or underarm is one possible symptom.
Other concerning changes may include swelling, skin dimpling, nipple changes, unusual discharge or a persistent change in the breast’s shape or appearance.
Not every change is cancer.
Many breast symptoms are caused by benign conditions.
However, women should contact a healthcare professional when they notice something new, unusual or persistent.
Bahl told People that the change she noticed did not match the familiar description of a hard, marble-like lump.
Her experience highlights why knowing what is normal for one’s own body can be useful.
The purpose of breast awareness isn’t to encourage constant anxiety or repeated self-examination.
It’s to recognize meaningful changes and seek appropriate evaluation.
Why Younger Women May Face Different Screening Decisions
Routine breast cancer screening recommendations depend on age, risk and the organization issuing the guidance.
For women at average risk, the U.S. Preventive Services Task Force recommends mammography every two years from ages 40 through 74.
The American Cancer Society offers somewhat different guidance: women ages 40 through 44 have the option to begin annual screening, women ages 45 through 54 should receive annual mammograms, and women 55 and older may transition to every-other-year screening or continue annually.
These recommendations apply to average-risk screening.
Women at higher risk may need a different plan, sometimes involving earlier mammography and breast MRI.
A strong family history, certain inherited genetic variants or previous chest radiation at a young age may influence those decisions.
Importantly, a woman with a new breast symptom needs a diagnostic evaluation rather than waiting until she reaches the age for routine screening.
Screening is intended to look for cancer before symptoms appear.
Diagnostic testing investigates a specific concern.
Those are different situations.
Family History Matters, but It Isn’t the Only Risk Factor
When women think about breast cancer risk, they often consider whether their mother or grandmother had the disease.
Family history can be important.
But breast cancer can also occur in women without a known family history.
Some inherited genetic changes, including certain BRCA1 and BRCA2 variants, substantially increase risk.
Other genetic factors and personal medical circumstances can also influence screening recommendations.
Women who are concerned about their risk can discuss family history with a healthcare professional.
That conversation may include relatives on both the mother’s and father’s sides of the family, since inherited cancer-related variants can be passed down through either parent.
Depending on the circumstances, a clinician may recommend formal risk assessment or genetic counseling.
The purpose is not to assume that every woman needs genetic testing.
It is to identify those who may benefit from a more individualized screening and prevention plan.
Researchers Want to Understand Why Age Can Change the Experience of Cancer
A breast cancer diagnosis can disrupt anyone’s life.
For younger women, however, the diagnosis may intersect with circumstances that are less common among older patients.
Some may be pregnant or planning to become pregnant.
Others may be raising young children.
They may be building careers, paying mortgages or managing other major financial responsibilities.
Treatment decisions may involve concerns about fertility preservation, pregnancy plans, work and long-term health.
Those considerations don’t change the need for effective cancer treatment, but they can influence the questions patients need answered.
Research focused specifically on younger women may help doctors better understand both the biology of the disease and the treatment decisions that arise at earlier ages.
The new initiative’s stated scientific priorities center on risk prediction, prevention, early detection and treatment.
Its potential importance is that these questions will be investigated with younger patients explicitly in mind.
Research Funding Has Not Always Reflected the Needs of Younger Patients
One statistic highlighted in the People report underscores the concern about research attention.
According to the Breast Cancer Research Foundation, an estimated 0.6% of breast cancer research funding since 2020 has focused on younger women.
That figure depends on how research projects are classified and should not be interpreted as meaning that only 0.6% of all breast cancer research has any relevance to younger patients.
Many studies involving broader patient populations may still produce findings that benefit younger women.
Nevertheless, the statistic illustrates why the foundation is emphasizing dedicated research into early-onset disease.
A study designed primarily around older patients may not answer every question relevant to women diagnosed in their 20s, 30s or early 40s.
Focused funding can help researchers investigate those questions more directly.
Breast Cancer Awareness Is About More Than Wearing Pink
October brings an enormous amount of attention to breast cancer.
Buildings are illuminated pink.
Companies launch fundraising campaigns.
Organizations share survivor stories and reminders about screening.
Those activities can raise awareness and support research.
But awareness becomes most useful when it leads to accurate information and appropriate action.
For a woman in her 30s, that might mean understanding her family history and knowing that a new breast change deserves medical attention even before routine screening age.
For a woman turning 40, it might mean discussing when to begin mammography based on the recommendations and her personal circumstances.
For someone with a strong family history, it might mean asking whether a formal risk assessment is appropriate.
And for women already undergoing treatment, it may mean learning about available support services and discussing the full range of treatment decisions with their medical team.
The message should not be that every unusual sensation indicates cancer.
It should be that age alone is not a reason to ignore a persistent or concerning change.
A New Research Initiative Could Help Answer Questions That Remain Unresolved
The $15 million commitment is significant, but it is only the beginning of the research effort.
The initiative is expected to operate over five years, bringing together scientists who study breast cancer from different perspectives.
Researchers hope to better understand why early-onset cancers develop, how their biology may differ and which approaches could improve outcomes.
Those answers may eventually influence how clinicians assess risk, detect disease and select treatments.
But the project should not be described as a cure or as proof that a new screening strategy is already available.
Its value lies in directing sustained research attention toward questions that remain unanswered.
For women diagnosed before 45, those questions are deeply personal.
They affect decisions about treatment, fertility, careers, family responsibilities and long-term health.
What Women Can Do While the Research Continues
Scientific progress takes time, but women don’t have to wait for the results of this initiative to take an active role in their breast health.
They can become familiar with how their breasts normally look and feel, report unusual changes and discuss screening recommendations with a healthcare professional.
Women with concerning family histories can ask whether they need an individualized risk assessment.
Those who notice a new lump, persistent skin change, unusual nipple discharge or another concerning symptom should seek medical evaluation rather than waiting for a routine screening appointment.
Breast self-awareness is not a substitute for recommended mammography or diagnostic testing.
And not every breast change is a sign of cancer.
The goal is informed attention rather than fear.
The Future of Breast Cancer Care May Depend on Asking More Specific Questions
For decades, breast cancer research has improved survival and expanded treatment options for many patients.
Targeted therapies, better imaging and a deeper understanding of tumor biology have changed how the disease is diagnosed and treated.
But progress also reveals new questions.
Why are diagnoses increasing among younger women?
Which biological differences matter most?
Can risk be identified earlier?
Could more precise detection and treatment improve outcomes?
The Global Research Initiative on Breast Cancer in Younger Women is designed to investigate those questions.
Its five-year, $15 million commitment represents an investment in understanding a population whose needs may not be fully captured by research focused on breast cancer overall.
For families, the larger lesson is that breast cancer awareness shouldn’t begin only when a woman reaches a traditional screening milestone.
It should include knowing personal risk, recognizing changes and understanding when to seek care.
Because although breast cancer becomes more common with age, younger women can develop it too.
And the more researchers learn about what makes those diagnoses different, the better equipped doctors may become to help the women and families facing them.
Original reporting: People, “Elizabeth Hurley Has Spent Decades Advocating for Breast Cancer Research. Now, She’s Calling Attention to a Growing Crisis,” October 9, 2026.
Research organization: Breast Cancer Research Foundation.
Screening guidance: U.S. Preventive Services Task Force, Breast Cancer Screening and American Cancer Society, Breast Cancer Screening Guidelines.